Clinical Trials Sponsored by Alberta Cancer Foundation

Total 3236 results

Alberta Health services

Completed

Review of Multimodality Management of Anaplastic Thyroid Cancer

Anaplastic Thyroid Cancer

Canada
Alberta Health services

Completed

Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community

Pain | Cancer | Hypercalcemia

Canada
Alberta Health services

Completed

Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer

Prostate Cancer

Canada
Alberta Health services

Completed

Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer

Breast Cancer

Canada
Alberta Health services

Completed

Pharmacist Discharge Medication Reconciliation Study

Medication Reconciliation

Canada
University of Alberta
University Hospital Foundation

Completed

Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis

Depression | Multiple Sclerosis | Anxiety | Patient Satisfaction

Canada
University of Alberta
University Hospital Foundation

Active, not recruiting

Multidisciplinary Support To Access Living Donor Kidney Transplant-Pilot (MuST AKT)

Living Donor Kidney Transplantation

Canada
Nanostics
Alberta Cancer Foundation; Alberta Innovates Health Solutions; Alberta Prostate... and other collaborators

Active, not recruiting

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer (APCaRI-05)

Prostate Cancer

Canada, United States
University of Alberta
Juvenile Diabetes Research Foundation; Diabetes Research Institute Foundation; Alberta Diabetes Institute and other collaborators

Active, not recruiting

PolyTreg Immunotherapy in Islet Transplantation

Diabetes | Diabetes Mellitus, Type 1

Canada
AHS Cancer Control Alberta

Recruiting

A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Prostate Cancer | Oncology

Canada
AHS Cancer Control Alberta

Recruiting

PSMA-PET/CT Registry

Prostate Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

Stem Cell Transplant Complications

Canada
AHS Cancer Control Alberta

Not yet recruiting

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

Gynecologic Cancer | Iron-deficiency | Anemia

Canada
AHS Cancer Control Alberta

Not yet recruiting

Nutritional Supplementation in Head and Neck Cancers

Nutritional Deficiency | Malnourishment | Undernutrition

Canada
AHS Cancer Control Alberta

Recruiting

A Study Involving Neoadjuvant Chemoradiotherapy With Hypofractionated Radiotherapy in Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma

Esophageal Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer (INSPIRE)

Anal Canal Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Prognostic Indicators for Radiation-induced Breast Fibrosis

Breast Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer (DARTS)

Small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Immune-Mediated Pathophysiology And Clinical Triage Program (IMPACT 2)

Arthritis | Arthralgia

Canada
AHS Cancer Control Alberta

Recruiting

A Nutritional Supplement to Support People With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Recruiting

A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use

Neuroendocrine Tumors

Canada
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy for Advanced Esophageal Cancer (PaRCUS)

Esophageal Cancer

Canada
AHS Cancer Control Alberta

Recruiting

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Breast Neoplasms

Canada
AHS Cancer Control Alberta

Active, not recruiting

Exercise and Compression for Lymphedema (DREAM)

Breast Cancer Related Lymphedema

Canada
AHS Cancer Control Alberta

Terminated

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Lymphoma | Cancer | Solid Tumor | Brain Cancer

Canada
AHS Cancer Control Alberta

Terminated

A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Breast Neoplasm

Canada
AHS Cancer Control Alberta

Completed

Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer

Colon Cancer

Canada
AHS Cancer Control Alberta

Completed

Comparative 2-D Tumor Analysis in Familial Gliomas

Malignant Glioma

Canada
AHS Cancer Control Alberta

Completed

Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy

Malignant Glioma

Canada
AHS Cancer Control Alberta

Unknown

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

Anal Canal Cancer

Canada
AHS Cancer Control Alberta

Unknown

Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating

Carcinoma, Non-Small-Cell Lung

Canada
AHS Cancer Control Alberta

Completed

Aerobic Capacity and Body Composition in Colon Cancer Patients

Colonic Neoplasms

Canada
AHS Cancer Control Alberta

Terminated

Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins

Colorectal Cancer | Lung Cancer

Canada
AHS Cancer Control Alberta

Completed

Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer

Cervix Cancer

Canada
AHS Cancer Control Alberta

Completed

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Head and Neck Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Glioblastoma
AHS Cancer Control Alberta

Unknown

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Pancreas Cancer

Canada
AHS Cancer Control Alberta

Unknown

Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer

Small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Unknown

A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer (Panc001)

Metastatic Pancreas Cancer

Canada
AHS Cancer Control Alberta

Terminated

Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection

Breast Neoplasms

Canada
University of Alberta
University Hospital Foundation

Completed

The Effect of Nurse Practitioner (NP-led) Care Upon Mood in People With Multiple Sclerosis

Multiple Sclerosis | Nurse's Role

Canada
University of Alberta
University Hospital Foundation

Completed

The Effect of Nurse Practitioner Led-Care on Quality of Life in Patients With Atrial Fibrillation

Atrial Fibrillation

Canada
AHS Cancer Control Alberta

Not yet recruiting

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)

Arthritis | Arthralgia
AHS Cancer Control Alberta

Not yet recruiting

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) (IMPACT 1)

Diarrhea | Advanced Melanoma | Immune-related Adverse Event | Advanced Rectal Carcinoma

Canada
AHS Cancer Control Alberta

Not yet recruiting

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Pancreatic Cancer | Cholangiocarcinoma | Biliary Tract Cancer | Hepatocellular Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

Breast Cancer Triple Negative

Canada
AHS Cancer Control Alberta

Recruiting

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (ACT-FAST)

Brain Metastases, Adult

Canada

3

Subscribe